Abiopharma

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Similarweb Announces Second Quarter 2026 Results

Marex Group Limited announces second quarter 2026 results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Recurrent Energy Powers Up Carwarp Energy Park in Australia Under Long-Term Microsoft PPA

SU Group Holdings Fortune Jet to Expand Security Training and Advisory Services Across Greater China